PMC:7402624 / 41552-42045 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T381","span":{"begin":243,"end":247},"obj":"Body_part"},{"id":"T382","span":{"begin":389,"end":394},"obj":"Body_part"},{"id":"T383","span":{"begin":427,"end":432},"obj":"Body_part"}],"attributes":[{"id":"A381","pred":"fma_id","subj":"T381","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A382","pred":"fma_id","subj":"T382","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A383","pred":"fma_id","subj":"T383","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ght different categories according to the NIH Ordinal Severity Scale ranging from COVID 1 (death) and COVID 2 (requiring maximal clinical intervention) to COVID 8 (at home with no required care) (Fig. 6A). We then asked how changes in T and B cell populations defined above on D0 were related to disease severity. More severe disease was associated with lower frequencies of CD8 and CD4 T cells, with a greater effect on CD8 T cells in less severe disease (Fig. 6B). Taking all patients togeth"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T17","span":{"begin":63,"end":68},"obj":"Body_part"}],"attributes":[{"id":"A17","pred":"uberon_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"ght different categories according to the NIH Ordinal Severity Scale ranging from COVID 1 (death) and COVID 2 (requiring maximal clinical intervention) to COVID 8 (at home with no required care) (Fig. 6A). We then asked how changes in T and B cell populations defined above on D0 were related to disease severity. More severe disease was associated with lower frequencies of CD8 and CD4 T cells, with a greater effect on CD8 T cells in less severe disease (Fig. 6B). Taking all patients togeth"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1474","span":{"begin":375,"end":378},"obj":"Gene"},{"id":"1475","span":{"begin":383,"end":386},"obj":"Gene"},{"id":"1476","span":{"begin":421,"end":424},"obj":"Gene"},{"id":"1482","span":{"begin":478,"end":486},"obj":"Species"},{"id":"1486","span":{"begin":82,"end":87},"obj":"Disease"},{"id":"1487","span":{"begin":91,"end":96},"obj":"Disease"},{"id":"1488","span":{"begin":102,"end":107},"obj":"Disease"},{"id":"1489","span":{"begin":155,"end":160},"obj":"Disease"}],"attributes":[{"id":"A1474","pred":"tao:has_database_id","subj":"1474","obj":"Gene:925"},{"id":"A1475","pred":"tao:has_database_id","subj":"1475","obj":"Gene:920"},{"id":"A1476","pred":"tao:has_database_id","subj":"1476","obj":"Gene:925"},{"id":"A1482","pred":"tao:has_database_id","subj":"1482","obj":"Tax:9606"},{"id":"A1486","pred":"tao:has_database_id","subj":"1486","obj":"MESH:C000657245"},{"id":"A1487","pred":"tao:has_database_id","subj":"1487","obj":"MESH:D003643"},{"id":"A1488","pred":"tao:has_database_id","subj":"1488","obj":"MESH:C000657245"},{"id":"A1489","pred":"tao:has_database_id","subj":"1489","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ght different categories according to the NIH Ordinal Severity Scale ranging from COVID 1 (death) and COVID 2 (requiring maximal clinical intervention) to COVID 8 (at home with no required care) (Fig. 6A). We then asked how changes in T and B cell populations defined above on D0 were related to disease severity. More severe disease was associated with lower frequencies of CD8 and CD4 T cells, with a greater effect on CD8 T cells in less severe disease (Fig. 6B). Taking all patients togeth"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T690","span":{"begin":241,"end":247},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T691","span":{"begin":375,"end":378},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T692","span":{"begin":383,"end":386},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T693","span":{"begin":387,"end":394},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T694","span":{"begin":401,"end":402},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T695","span":{"begin":421,"end":424},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T696","span":{"begin":425,"end":432},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"ght different categories according to the NIH Ordinal Severity Scale ranging from COVID 1 (death) and COVID 2 (requiring maximal clinical intervention) to COVID 8 (at home with no required care) (Fig. 6A). We then asked how changes in T and B cell populations defined above on D0 were related to disease severity. More severe disease was associated with lower frequencies of CD8 and CD4 T cells, with a greater effect on CD8 T cells in less severe disease (Fig. 6B). Taking all patients togeth"}

{"project":"LitCovid-sentences","denotations":[{"id":"T241","span":{"begin":206,"end":313},"obj":"Sentence"},{"id":"T242","span":{"begin":314,"end":466},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ght different categories according to the NIH Ordinal Severity Scale ranging from COVID 1 (death) and COVID 2 (requiring maximal clinical intervention) to COVID 8 (at home with no required care) (Fig. 6A). We then asked how changes in T and B cell populations defined above on D0 were related to disease severity. More severe disease was associated with lower frequencies of CD8 and CD4 T cells, with a greater effect on CD8 T cells in less severe disease (Fig. 6B). Taking all patients togeth"}